Last update :
03/05/2024
References   References 4062  
Type : Journal
Web link : https://ijpc.com/Abstracts/Abstract.cfm?ABS=4436

Research teams : Waltham - TESARO Inc, Waltham
Authors : Wu George, Powers Dan, Yeung S, Chen F, Neelon K.
Title : Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous palonosetron hydrochloride injection and dexamethasone sodium phosphate injection.
Reference : Int J Pharm Compound ;22,1:76-85 2018

Level of Evidence : 
Level of evidence C+
Physical stability : 
Visual examination Turbidimetry Particle counting 
Chemical stability : 
High Performance Liquid Chromatography - ultraviolet detector (HPLC-UV)
Stability defined as 95% of the initial concentration
Other methods : 
PH measurement 
Comments : 
Results with high coefficient of variation or not provided, or lack of duplicate analysis of each point
Degradation products not observed in real conditions

List of drugs
InjectionDexamethasone sodium phosphate Anti-inflammatory
InjectionPalonosetron hydrochloride Antiemetic
InjectionRolapitant Antiemetic
Stability of mixtures
Glass None 2-8°C Protect from light
Injection Rolapitant 1,6 mg/ml
Injection Palonosetron hydrochloride 2,1 µg/ml
Injection Dexamethasone sodium phosphate 0,178 mg/ml
48 Hour
Glass None 2-8°C Protect from light
Injection Rolapitant 1,6 mg/ml
Injection Palonosetron hydrochloride 2,1 µg/ml
Injection Dexamethasone sodium phosphate 0,093 mg/ml
48 Hour
Glass None 20-25°C Light
Injection Rolapitant 1,6 mg/ml
Injection Palonosetron hydrochloride 2,1 µg/ml
Injection Dexamethasone sodium phosphate 0,093 mg/ml
24 Hour
Glass None 20-25°C Light
Injection Rolapitant 1,6 mg/ml
Injection Palonosetron hydrochloride 2,1 µg/ml
Injection Dexamethasone sodium phosphate 0,178 mg/ml
24 Hour

  Mentions Légales